Skip to search formSkip to main contentSkip to account menu

Apolipoproteins A measurement

Known as: APOA, Apolipoprotein A, Apo A Measurement 
The determination of the amount of apolipoprotein A present in a sample.
National Institutes of Health

Related topics

Related topics

5 relations
Apolipoproteins AApoprotein(a)CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by Name

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Potent and Selective PPAR-α Agonist LY518674 Upregulates Both ApoA-I Production and Catabolism in Human Subjects With the Metabolic Syndrome
Objective—The study of PPAR-α activation on apoA-I production in humans has been limited to fibrates, relatively weak PPAR… 
2007
2007
LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
To explain the etiology and find a mode of therapy of genetically determined low levels of high-density lipoprotein (HDL), we… 
2007
2007
Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
In the present study we have used adenovirus-mediated gene transfer of apoA-I (apolipoprotein A-I) mutants in apoA-I-/- mice to… 
Highly Cited
2002
Highly Cited
2002
Mast Cell Chymase Degrades ApoE and ApoA-II in ApoA-I–Knockout Mouse Plasma and Reduces Its Ability to Promote Cellular Cholesterol Efflux
Objective—Mast cell chymase is a chymotryptic heparin proteoglycan–bound neutral protease that exerts its activity in… 
2000
2000
Changes in paraoxonase and apolipoprotein A-I, B, C-III and E in subjects with combined familiar hyperlipoproteinemia treated with ciprofibrate.
The aim of our study was to determine whether, in patients with familiar combined hyperlipoproteinemia (FCH), ciprofibrate… 
1997
1997
Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I.
We studied a Norwegian patient and his family, who presented with low HDL-cholesterol. DNA sequence analysis of the apoA-I gene… 
Highly Cited
1984
Highly Cited
1984
Serum apolipoprotein A-I, A-II and B levels and their discriminative values in relatives of patients with coronary artery disease.
Highly Cited
1982
Highly Cited
1982
Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).
Tangier disease is a rare familial disorder characterized by enlarged orange tonsils, transient peripheral neuropathy… 
1980
1980
The effect of chronic cholesterol feeding on intestinal lipoproteins in the rat.
Highly Cited
1978
Highly Cited
1978
Abnormal concentration and anomalous distribution of apolipoprotein A-I in Tangier disease.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)